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Background: Malnutrition-related conditions such as protein energy wasting are affecting poor outcome of the
dialysis population. The serum albumin level is often used as a marker of wasting and malnutrition. However,
the serum albumin level can be affected by the presence of inflammation as well as by nutritional status. We
investigated associations between serum albumin values adjusted with C-reactive protein (CRP) and mortality in
hemodialysis (HD) patients.
Methods: A total of 397 HD patients were included in this study. The patient characteristics and laboratory data,
including serum albumin and CRP levels, were obtained in July 2012. Survival as of the end of August 2014
(maximum follow-up period 25 months) was investigated. First, the regression line was obtained from the entire
population between serum albumin and CRP levels. Next, the CRP-adjusted albumin levels were determined
as a dichotomized variable with the patients having higher albumin values above the regression line. We
investigated associations between three albumin indices (the actual values, the dichotomized index by median,
and CRP-adjusted values) and mortality by using Cox proportional hazard models.
Results: The average age of the 397 HD patients was 70.6 years old; 258 were male, and 44.6% were diabetic.
Median dialysis vintage was 3.6 years. There were 73 deaths during the observation period. A univariate Cox
analysis demonstrated that all three indices were associated with survival, and the hazard ratio (HR) was 0.40 (95%
confidence interval (CI) 0.25–0.68) for increase in albumin level, 0.41 (95% CI 0.25–0.68) for higher dichotomized
albumin level by median, and 0.46 (95% CI 0.28–0.74) for higher CRP-adjusted albumin level, but only higher CRP-
adjusted albumin level was associated with better survival (HR 0.51, 95% CI 0.30–0.85). The degree to which the
deviation of albumin was attributable to that of CRP was 12.6%. The analyses on cause-specific mortality revealed
that lower albumin levels were associated significantly with infection-related mortality but were not significantly
associated with death due to congestive heart failure.
Conclusions: CRP-adjusted albumin was shown to be a better predictor of mortality among the HD patients. When
assessing serum albumin values, inflammatory status should be taken into account. Malnutrition or wasting was
shown to be associated with a poor outcome independent of inflammation.
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The dialysis population in Japan is becoming older.
Malnutrition-related conditions such as protein energy
wasting (PEW) [1–4], sarcopenia [5, 6], and frailty [4, 7]
draw attentions among such older dialysis populations.
Many studies have investigated the relationship between
malnutrition and patient outcome, and the results have
revealed that malnutrition-related conditions are associ-
ated with a poor outcome [5–7].
To investigate the best index that reflects malnutrition
is a matter of debate [8–12]. The serum albumin level is
one of the most popular indexes of malnutrition [2, 8, 11,
12]. Albumin reportedly relates to the poor survival in ori-
ginal values [13], together with in a form of geriatric nutri-
tional risk index (GNRI) [11]. However, starvation does
not necessarily reduce albumin values [14], and the in-
flammatory state that often coincides with malnutrition in
dialysis populations [1] largely affects the lower albumin
values [14]. Thus, the serum albumin level might not be a
suitable marker of malnutrition in dialysis patients.
We speculated that the values that deducted the effect
of inflammation from the actual albumin might become
a better marker of malnutrition compared to the original
albumin values independent of the effect of inflamma-
tion. We therefore performed a study to investigate the
relationship between the serum albumin levels and C-
reactive protein (CRP) levels, and thereafter, the albumin
values adjusted with CRP were investigated from the
perspective of all-cause mortality of hemodialysis (HD)
patients.
Methods
Design and population
This was a retrospective, observational cohort study
conducted at a single center in Japan. The potential
population was the chronic dialysis population that was
on HD therapy through an arteriovenous fistula at Jyo-
ban Hospital, Iwaki, Japan, in July 2012. HD patients
with a malignancy, active inflammation, liver cirrhosis,
gastrointestinal bleeding, cardiac valvular disease, or se-
vere illness were excluded from participation and were
transferred to another dialysis unit for intensive care.
We also excluded the data of patients who did not con-
sent to participate in this study. The Institutional Review
Board of the Jyoban Hospital approved the study proto-
col; the approval number is 25-(3). The protocols were
carried out in accordance with the Declaration of
Helsinki guidelines regarding ethical principles for med-
ical research involving human subjects. Informed con-
sent was obtained from every subject.
Laboratory measurements
The laboratory data were obtained on the basis of daily
clinical practice. The biochemistry data and completeblood counts were obtained on the first day of each
week. All measurements were made except the blood
urea nitrogen (BUN) level before a dialysis session. BUN
level was measured both before and after the dialysis
session. Serum creatinine, calcium, phosphorus, albu-
min, total cholesterol, high-density lipoprotein (HDL)
cholesterol, and triglyceride were measured with an
autoanalyzer by standard laboratory methods. The serum
calcium values were corrected with albumin level. Intact
parathyroid hormone (iPTH) was measured by an
immunoradiometric assay. Body mass index (BMI) was
expressed in kg/m2. Body weight was calculated as dry
weight, defined as post-dialysis weight in which the
patient was normotensive and with no signs of overhydra-
tion. Urea kinetics were assessed by measuring a blood-
based dialysis parameter, Kt/V [15], and the mean value of
the three measurements during each of the 3 months be-
fore the start of the study was used in the analysis. The
normalized protein catabolic rate (nPCR) was used as an
indirect indicator of protein intake and was calculated by
using the formula previously reported [16].
The history of cardiovascular disease was defined from
medical records showing previous heart failure, myocar-
dial infarction, angina pectoris, stroke, coronary artery
disease combined with stent implantation, and periph-
eral artery disease combined with percutaneous translu-
minal angioplasty.
Clinical outcomes
Endpoints were obtained from the hospital charts and
by telephone interview with patients that were con-
ducted by trained interviewers who were blinded to the
study protocol. The primary endpoint of this study was
all-cause mortality during the follow-up period, from
July 1, 2012 to August 31, 2014. The vital status of the
subjects was assessed by searching their electronic dialy-
sis records. Patients were censored if the patient was
alive on August 31, 2014.
Statistical analyses
For the descriptive analysis, the mean values and stand-
ard deviations or median and interquartile ranges (IQRs)
were used for normally or non-normally distributed con-
tinuous variables. Categorical variables were summarized
by numbers and proportion.
The relationship between serum albumin and CRP
levels was determined. Linear regression analysis was
performed, and the predictive equation of albumin
adjusted with CRP was determined. CRP is known to
have a log-transformed normal distribution, and log
CRP values were used to evaluate the relationship be-
tween the CRP and albumin. From the equation, the
predicted albumin values that were adjusted with CRP
levels were determined.
Table 1 Baseline background factors of the subjects
Items Values
Age (years) 70.6 ± 13.4 (median 72, IQR 62–81)
Gender (female/male) 139/258
Primary diagnosis (person, %)
Diabetes 177 (44.6%)
Nephrosclerosis 94 (23.7%)
Glomerulonephritis 76 (19.1%)
Others 50 (12.6%)
Dialysis vintage (years) Median 3.6, IQR 1.6–7.5
History of cardiovascular
diseases (person, %)
103 (25.9%)
History of smoking (persons, %) 152 (43.3%, unknown excluded
from the population)
Physical indices
Body height (cm) 159.3 ± 9.9
Dry weight (kg) 56.6 ± 12.2
Body mass index (kg/m2) 22.1 ± 3.8
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min indices as the main predictors. We used albumin in-
dices in three ways: actual values, albumin dichotomized
by the median, and CRP-adjusted albumin that was de-
termined as high or low values, if the actual albumin
values were higher or lower than predicted by the CRP
levels. We performed Kaplan-Meier analyses followed by
log-rank tests for the dichotomized albumin values by
the median and CRP-adjusted albumin. Next, a Cox pro-
portional hazard model was employed to evaluate sur-
vival effects of albumin. First, we performed univariate
analyses, and then the models were adjusted for age,
gender, diabetes, dialysis vintage, nPCR, and logCRP.
Dialysis vintages were divided into four groups (<2 years,
2–4 years, 4–8 years, ≥8 years). Because the median dia-
lysis vintage was 3.6 years and IQR was 1.6–7.5, such
limits yielded almost quartilized groups in terms of the
length of dialysis vintage. We used <2-year dialysis vin-
tage group as the reference group. The effects of vari-
ables are expressed in the form of hazard ratios (HRs)
and 95% confidence intervals (CIs).
We also performed similar survival analyses for the
mortalities due to congestive heart failure and infective
diseases. The causes of death were collected as the forms
of semi-categorized disease entities. The deaths due to
congestive heart failure were defined as the death due to
itself, while the deaths due to infection included sepsis,
pneumonia, and acute cholecystitis. The numbers of the
deaths due to either congestive heart failure or infection
were limited. Thus, in the multivariate analyses to inves-
tigate the associations of each albumin index with the
cause-specific mortalities, we only adjusted age, gender,
and diabetes as primary diagnoses. Actually, the num-
bers of deaths due to infection were small, and there
remains a concern that we included more variables to
adjust in the models. The degree of model fittings was
also evaluated by the corrected Akaike’s Information
Criteria (AICc). Furthermore, in order to investigate
more detailed association, we also made a cross table for
the numbers of the deceased patients by dichotomized
albumin values and CRP-adjusted albumin values. The
significance of this association was investigated by
Fisher’s exact test.
The JMP 11.2.0 software program (SAS Institute Inc.,
NC, USA) was used to perform the statistical analysis.
Results
Patient characteristics are shown in Table 1. The average
age of the patients was 70.6 years old, which was slightly
higher than the average age of total HD population of
Japan (67.2 ± 12.5 years old at the end of 2013) [15].
Diabetes and nephrosclerosis were the predominant pri-
mary diagnoses. One fourth of the patients had a history
of cardiovascular disease.The laboratory data are summarized in Table 2. The
mean serum albumin value was 3.62 ± 0.38 g/dl (median
3.7, IQR 3.4–3.9). The median serum CRP value was
0.14 mg/dl, and the IQR was 0.05–0.38 mg/dl, which
can be rephrased as logCRP −0.84 ± 0.62 (log mg/dl).
Figure 1 shows the relationship between the logCRP
and albumin values, and a weak but significant correl-
ation was found between the two sets of values. The re-
gression equation was albumin (g/dl) = 3.438 − 0.215
logCRP (log mg/dl). The degree of fitting was expressed
as R2 = 0.126, which means that 12.6% of the albumin
distribution was determined by the logCRP value.
The numbers of patients who died during the study
period and their causes of death are summarized in
Table 3. In total, 73 patients had died from all causes.
The most common cause of death was heart failure
(42.5%), and it was followed by infection (23.3%) and
cerebrovascular disease (11.0%).
Kaplan-Meier analyses followed by log-rank tests
demonstrated that both the higher dichotomized and
CRP-adjusted albumin level groups were significantly as-
sociated with better survival (Fig. 2a, b). The univariate
analysis was performed to investigate the relationships
between each value and the all-cause mortality, and sig-
nificant associations were found with age, log CRP, and
albumin (Table 4). The relationship between serum albu-
min levels and mortality was investigated in three ways,
as described above. The first was the actual value, the
second was the dichotomized value, and the last was the
albumin values adjusted with CRP. The CRP-adjusted
albumin values were the dichotomized value that was
determined by the albumin predicted from CRP values
with the use of the regression equation, i.e., predicted
Table 2 Baseline laboratory data of the subjects
Items Measurements
Systolic blood pressure (mmHg) 153.5 ± 17.6
Diastolic blood pressure (mmHg) 80.0 ± 12.1
Pulse rate (per minute) 73.5 ± 13.4
Albumin (g/dl) 3.62 ± 0.38 (median 3.7, IQR 3.4–3.9)
CRP (mg/dl) Median 0.14, IQR 0.05–0.38
(range 0.01–15.54)
LogCRP (log mg/dl) −0.84 ± 0.62 (median −0.85,
IQR −1.30 to −0.42)
Hemoglobin (g/dl) 10.5 ± 1.3
Ferritin (ng/ml) Median 60, IQR 23–123
Transferrin saturation (%) 24.7 ± 13.2
Total cholesterol (mg/dl) 152.7 ± 33.0
HDL cholesterol (mg/dl) 46.2 ± 13.8
Triglyceride (mg/dl) 113.1 ± 71.7 (median 94, IQR 64–138)
LDL cholesterol (mg/dl) 83.8 ± 28.0
Albumin-corrected calcium (mg/dl) 9.08 ± 0.65
Phosphate (mg/dl) 4.67 ± 1.75
Intact PTH (pg/ml) Median 101, IQR 54–179
Kt/V 1.34 ± 0.27
nPCR (g/kg/day) 0.83 ± 0.19
CRP C-reactive protein, HDL high-density lipoprotein, LDL low-density lipoprotein,
PTH parathyroid hormone, and nPCR normalized protein catabolic rate
Fig. 1 Relationship between log CRP values and serum albumin values. A s
regression line was obtained by the least squares method. The albumin valu
values, and the values below the regression line low CRP-adjusted serum album
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predicted values were smaller than the actual values, the
CRP-adjusted albumin values were determined as low,
vice versa. All three indices were significantly negatively
correlated with all-cause mortality.
We investigated the predictive power of three albumin
indices adjusted by age, gender, diabetes, dialysis vintage,
nPCR, and logCRP. The HR for these indices was 0.60
(95% CI 0.29–1.23) for the actual serum albumin values,
0.64 (95% CI 0.37–1.08) for the dichotomized albumin
values, and 0.51 (95% CI 0.30–0.85) for the CRP-
adjusted albumin values. As a result, only CRP-adjusted
albumin value was significantly associated with the
poorer outcome (Table 5).
For cause-specific analyses, the lower groups for the
albumin indices tended to be associated with lower mor-
tality due to congestive heart failure but did not reach
their significances by crude models. The HRs (and 95%
CIs) for albumin indices were 0.44 (0.21–1.03), 0.52
(0.24–1.08), and 0.67 (0.32–1.37), for actual albumin
values, dichotomized albumin values by the median, and
CRP-adjusted albumin values, respectively. This associ-
ation did not change even after adjustment of age,
gender, and diabetes as primary diagnosis (Table 6). AICc is
an index of the degree of model fitting, and the lower value
demonstrates better model fitting. AICc demonstrated thatcatter plot of log CRP values and serum albumin values is shown. The
es above the regression line were considered high CRP-adjusted albumin
in values
Table 3 Causes of death
Causes for death Numbers (%)
All causes 73
Cause-specific
Heart failure 31 (42.5%)
Infection 17 (23.3%)
Cerebrovascular 8 (11.0%)
Malignancy 5 (6.8%)
Myocardial infarction 5 (6.8%)
Gastrointestinal bleeding 4 (5.5%)
Other causes 3 (4.1%)
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model fitting compared to other indices.
On the other hand, the associations between albumin
indices and death due to infection were significant for all
of the indices investigated by crude models. The HRs
(and 95% CIs) for albumin indices were 0.22 (0.09–0.58),
0.12 (0.02–0.42), and 0.12 (0.02–0.41), for actual albu-
min values, dichotomized albumin values by the median,
and CRP-adjusted albumin values, respectively. The as-
sociations did not change their significances. However,
the CRP-adjusted albumin levels demonstrated the lower
HR compared to that of the dichotomized albumin by
the median. AICc of the model which included CRP-
adjusted albumin was also the lowest among the three
models, which indicates the model exhibited the best fit-
ting (Table 7).
Table 8 indicated that the patients in the group with
lower dichotomized by the median and lower CRP-
adjusted albumin levels demonstrated higher infection-
related mortality (p < 0.001), while the patients in the
group with higher dichotomized by the median and
higher CRP-adjusted levels demonstrated better survival
(p = 0.005).
Discussion
The results of this study showed that 12.6% of the devi-
ation of albumin was determined by CRP. The CRP-
adjusted albumin value was the only index associated
with a poorer outcome of the chronic HD patients in
this study. This result means that malnutrition or wast-
ing itself was associated with survival, independent of
the inflammation status, or protein intake of the chronic
HD patients in this study. The analyses for cause-
specific death demonstrated that such association was
evident for death due to infection but not for congestive
heart failure.
PEW is a condition in which visceral protein and fat
stores decrease as a result of many chronic comorbid
conditions, including chronic kidney disease [1, 2]. Since
PEW has been shown to be associated with a pooroutcome in many clinical investigations [1, 3, 4], strat-
egies to combat PEW have been anticipated and
discussed [1, 3]. The International Society of Renal Nu-
trition and Metabolism published diagnostic criteria for
PEW [2]. The guideline employed four clinical indices:
serum chemistry (low serum levels of albumin, prealbu-
min, and cholesterol), body mass (reduced BMI, weight
loss, and reduction of total body fat), muscle mass
(muscle wasting, anthropometry, and creatinine appear-
ance), and dietary intake (low dietary protein intake and
energy intake) [2]. Thus, reduced serum albumin level is
closely related to PEW. Actually, the population with
even minimal reduction of albumin as well as low
albumin values reportedly experiences poor survival
[13]. The results from Kaplan-Meier analyses of this
study confirmed such effects of albumin on mortality
and demonstrated that lower albumin levels related to
worse outcome.
Albumin is synthesized in the liver, and albumin syn-
thesis is influenced by inflammation status [16] and
amino acid pools [17, 18]. Moreover, inflammatory sta-
tus shortens the half-life of serum albumin [19]. Serum
albumin level is therefore considered as an index of both
inflammation and wasting or malnutrition [1, 14]. How-
ever, since dietary restriction does not always lead to a
reduction in serum albumin level [14], the significance
of inflammation has been postulated and been shown to
outweigh the effect of malnutrition in determining the
serum albumin levels [14]. Likewise, the reduction of the
serum albumin level is not necessarily caused by the
malnutrition itself [14]. An experiment in 1944 to 1945
investigated the effect of starvation on the physiological
and psychological aspects of healthy volunteers. The
results showed that only a limited reduction in serum al-
bumin level (from 4.3 ± 0.5 to 3.9 ± 0.5 g/dl) was ob-
served even after a severe decrease in body mass (BMI:
from 21.7 ± 1.7 to 16.4 ± 0.9 kg/m2) [14]. Moreover, the
inflammation-related conditions or wasting are consid-
ered to have larger impacts on the reduction of albumin
levels [3]. Actually, the results of the present study
indicated that 12.6% of deviation in albumin values was
derived from those of CRP. Therefore, the degree was
not so large, but it was demonstrated that albumin could
be influenced by inflammation.
HD patients are prone to have inflammatory status be-
cause of the vascular access [20], periodontal diseases
[21], bacterial translocation from the altered microbiome
in the gut [22], or immunodeficiency [23]. The presence
of inflammation can be related to worse survival among
HD patients [24, 25]; the HD patients with higher serum
CRP level have higher mortality rates [25]. However, the
serum CRP levels of our study population were no lon-
ger associated with the poor outcome after adjustment
for the serum albumin levels. This finding indicated that
Fig. 2 The survivals of the groups with the higher and lower albumin indices. The Kaplan-Meier analyses and log-rank tests were performed for
the dichotomized (a) or CRP-adjusted (b) albumin values. The blue lines indicate the higher group, and the red lines indicate the lower group. The
higher groups for both indices exhibited the better survival compared to the lower groups
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larger impact on the better health of HD patients com-
pared to inflammation.This study demonstrated that such association was
most evident for death due to infection. A study investi-
gated the effect of albumin, which was not adjusted for
Table 4 Univariate analysis of the associations between clinical
indices and all-cause mortality
Parameters HR (95% CI)
Age (per 1 year) 1.07 (1.05–1.09)
Gender (female) 0.71 (0.42–1.17)
Diabetes 1.53 (0.96–2.44)
Dialysis vintage (years)
<2 Reference
≥2 and <4 0.85 (0.45–1.59)
≥4 and <8 0.84 (0.44–1.54)
≥8 0.76 (0.36–1.44)
nPCR (per 1 g/kg/day) 0.61 (0.18–2.02)
LogCRP (per 1 log mg/dl) 1.79 (1.25–2.54)
Actual albumin (per 1 g/dl) 0.40 (0.25–0.68)
Dichotomized albumin by median (the higher group) 0.41 (0.25–0.68)
CRP-adjusted albumin (the higher group) 0.46 (0.28–0.74)
nPCR normalized protein catabolic rate, CRP C-reactive protein, HR hazard ratio,
and CI confidence intervals
Table 6 Predictive power of each of the different albumin
indices on mortality due to congestive heart failure
Parameters Model 1 Model 2 Model 3
Age (per 1 year) 1.09 (1.05–1.13) 1.09 (1.05–1.14) 1.09 (1.05–1.13)
Gender (female) 0.57 (0.25–1.23) 0.56 (0.24–1.19) 0.55 (0.24–1.19)
Diabetes 1.65 (0.79–3.46) 1.64 (0.78–3.44) 1.66 (0.80–3.47)
Actual albumin
(per 1 g/dl)
0.71 (0.27–1.89) – –
Dichotomized
albumin by median
(the higher group)
– 0.85 (0.38–1.82) –
CRP-adjusted albumin
(the higher group)
– – 0.87 (0.41–1.80)
Corrected Akaike’s
Information Criteria
335.1 335.4 335.4
CRP C-reactive protein
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peritoneal dialysis [26]. The study found that the HRs of
low albumin levels for infection-related mortality were
higher than those for cardiovascular mortality irrespect-
ive of dialysis modalities. Our study confirmed this result
even by CRP-adjusted albumin. Moreover, the group
with the lower CRP-adjusted albumin values moreTable 5 Predictive power of each of the different albumin
indices
Parameters Model 1 Model 2 Model 3
Age (per 1 year) 1.08 (1.05–1.11) 1.08 (1.05–1.11) 1.08 (1.05–1.10)
Gender (female) 0.50 (0.28–0.87) 0.49 (0.27–0.84) 0.50 (0.28–0.86)
Diabetes 1.82 (1.12–2.96) 1.77 (1.09–2.88) 1.84 (1.14–3.00)
Dialysis vintage (years)
<2 Reference Reference Reference
≥2 and <4 0.84 (0.42–1.66) 0.78 (0.40–1.47) 0.89 (0.45–1.70)
≥4 and <8 0.90 (0.46–1.72) 0.84 (0.44–1.56) 0.92 (0.48–1.73)
≥8 1.35 (0.65–2.71) 1.31 (0.64–2.57) 1.39 (0.68–2.70)
nPCR (per 1 g/
kg/day)
2.30 (0.64–7.90) 2.16 (0.62–7.29) 2.28 (0.66–7.55)
Log CRP (per 1
log mg/dl)
1.21 (0.81–1.80) 1.24 (0.84–1.82) 1.43 (0.97–2.10)
Actual albumin
(per 1 g/dl)
0.60 (0.29–1.23) – –
Dichotomized
albumin by median
(the higher group)
– 0.64 (0.37–1.08) –
CRP-adjusted
albumin
(the higher group)
– – 0.51 (0.30–0.85)
nPCR normalized protein catabolic rate, CRP C-reactive protein, HR hazard ratio,
and CI confidence intervalsignificantly associated, which was shown by the lower
AICc score, with higher infection-related mortality com-
pared to albumin indices. The fact indicated that lower
albumin without the effect of inflammatory status was
more likely associated with the death due to infection.
Further studies are required to investigate whether
hypoalbuminemia itself [13] or malnutrition existing
in the background [27] is associated with infection-
related mortality.
On the other hand, albumin values were not signifi-
cantly associated with survival for the death due to con-
gestive heart failure, though the point estimates of HRs
favored the higher albumin values for all indices. This
fact indicates that low albumin values can relate to the
death due to congestive heart failure, but other factors
seemed more likely to be associated with such mortality.
Moreover, interestingly enough, CRP-adjusted albumin
levels were no longer significant compared to other al-
bumin indices. The previous reports demonstrated thatTable 7 Predictive power of each of the different albumin
indices on mortality due to infection
Parameters Model 1 Model 2 Model 3
Age (per 1 year) 1.15 (1.08–1.22) 1.14 (1.07–1.21) 1.14 (1.07–1.21)
Gender (female) 0.60 (0.20–1.66) 0.53 (0.18–1.44) 0.49 (0.16–1.34)
Diabetes 4.21 (1.52–13.5) 3.81 (1.38–12.2) 4.04 (1.46–13.0)
Actual albumin
(per 1 g/dl)
0.24 (0.07–0.93) – –
Dichotomized
albumin by median
(the higher group)
– 0.25 (0.04–0.93) –
CRP-adjusted albumin
(the higher group)
– – 0.17 (0.03–0.62)
Corrected Akaike’s
Information Criteria
169.4 169.3 165.9
nPCR normalized protein catabolic rate, CRP C-reactive protein, HR hazard ratio,
and CI confidence interval
Table 8 Distribution of the numbers of deceased patients.
Predictive power of each of the different albumin indices on
mortality due to infection
CRP-adjusted albumin
The higher group The lower group
Dichotomized
albumin
by median
The higher
group
2/180 (1.11%) 0/21 (0%)
The lower
group
0/25 (0%) 15/170 (8.82%)
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eases [28, 29]. However, it has been demonstrated
that there are many other cardiovascular risk factors,
and the condition is known as cardiorenal syndrome
type 4 [30]. The present study confirmed that the
death due to congestive heart failure might be asso-
ciated with hypoalbuminemia itself, but more sub-
stantially with other risk factors as well. These
associations require further investigations among lar-
ger cohorts.
Several indices, including the malnutrition-inflammation
score [8] or GNRI [12], have been proposed to monitor the
nutritional status of HD populations, and they have been
reported to be good predictors of patient outcome [8, 11].
However, from a clinical standpoint, serum albumin levels
can be monitored easily and are widely used to assess global
nutritional status. The results of the present study demon-
strated that it is important to consider inflammatory status
of HD patients when assessing their serum albumin levels.
This finding also indicates that malnutrition or wasting can
affect the outcome of the patients independent of their
inflammation status, thereby confirming the value of
nutritional interventions to combat malnutrition in
HD populations [1].
Limitations
This study had several limitations. The first limitation
was that it was performed on the basis of observa-
tional study, and thus, the cause result relationship
cannot be drawn whether the outcome can be im-
proved by the increase of serum albumin levels in
face of higher CRP or the reduction of CRP in face
of lower albumin levels. Second, this study was per-
formed on the database of a single center. Further
generalizability of the present investigation will be re-
quired by the study using the data of other cohorts.
The final limitation was that only the baseline data
were analyzed, and no changes in clinical indices, in-
cluding albumin or CRP values, were considered. Sub-
stantial changes in the clinical parameters could take
place afterward during the course. However, this
study had several advantages. First, the total number
of patients was substantial, and we were able to ob-
tain a conclusion from this HD population. Second,the follow-up period and the numbers of outcomes
are also sufficient to be investigated. Third, since the pa-
tient background factors almost matched those of the en-
tire Japanese HD population. Therefore, the cohort in
our study was the representative of the Japanese HD
population.
Conclusions
When assessing the serum albumin levels of HD
population, the inflammation status of the patients
should be taken into consideration. Wasting or mal-
nutrition itself can predict a worse outcome inde-
pendent of inflammation.
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